Modelling the cost effectiveness of cholinesterase inhibitors in the management of mild to moderately severe Alzheimer's disease

被引：8

作者：

Bosanquet, N ^{[1
]}

Yeates, A

机构：

[1] Imperial Coll Sch Med, London, England

[2] Eisai Europe Ltd, London, England

来源：

PHARMACOECONOMICS | 2006年 / 24卷 / 06期

关键词：

D O I：

10.2165/00019053-200624060-00008

中图分类号：

F [经济];

学科分类号：

02 ;

摘要：

引用

页码：623 / 625

页数：3

共 50 条

[41] Cholinergic adverse effects of cholinesterase inhibitors in Alzheimer's disease - Epidemiology and management
Gauthier, S
DRUGS & AGING, 2001, 18 (11) : 853 - 862
[42] Cost-benefit analysis of cholinesterase inhibitors (ChEI) in Alzheimer's disease (AD).
Lanctôt, KL
Oh, PI
Risebrough, N
Herrmann, N
CLINICAL PHARMACOLOGY & THERAPEUTICS, 1999, 65 (02) : 169 - 169
[43] Cholinesterase Inhibitors May Not Benefit Mild Cognitive Impairment and Mild Alzheimer Disease Dementia
Han, Jee-young
Besser, Lilah M.
Xiong, Chengjie
Kukull, Walter A.
Morris, John C.
ALZHEIMER DISEASE & ASSOCIATED DISORDERS, 2019, 33 (02): : 87 - 94
[44] Cholinesterase inhibitors for Alzheimer disease
Finucane, TE
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2003, 289 (18): : 2359 - 2359
[45] Efficacy of rivastigmine over 4 years in mild, moderate and moderately severe Alzheimer's disease
Kaufer, D
Quarg, P
Spiegel, R
INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2004, 7 : S210 - S210
[46] The efficacy and safety of ENA-713 in patients with mild to moderately severe Alzheimer's disease
Corey-Bloom, J
JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 1998, 46 (09) : S12 - S12
[47] Cholinesterase inhibitors affect disease progression in Alzheimer's disease
Marini, S.
Bessi, V.
Padiglioni, S.
Nacmias, B.
Bagnoli, S.
Sorbi, S.
Bracco, L.
JOURNAL OF NEUROLOGY, 2013, 260 : S165 - S165
[48] Adherence to Cholinesterase Inhibitors in Alzheimer's Disease: A Review
Brady, Roseanna
Weinman, John
DEMENTIA AND GERIATRIC COGNITIVE DISORDERS, 2013, 35 (5-6) : 351 - 363
[49] Current treatments for Alzheimer's disease: Cholinesterase inhibitors
Doody, RS
JOURNAL OF CLINICAL PSYCHIATRY, 2003, 64 : 11 - 17
[50] Switching cholinesterase inhibitors in patients with Alzheimer's disease
Emre, M
INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 2002, : 64 - 72

← 1 2 3 4 5 →